Error innat del metabolisme diagnosticat després d'encefalopatia hiperamonièmica induïda per valproat

Zambrano Pey, Susana; Jiménez Vila, Guillem; Raspall Chaure, Miquel; Arranz Amo, José Antonio; Toro Riera, Mireia del; Felipe-Rucián, Ana.
Pediatr. catalan ; 81(4): 179-182, Oct-Dic. 2021. ilus
Artículo en Ca | IBECS (España) | ID: ibc-218257

Documentos relacionados

  1. [Valproate in the treatment of epilepsy and status epilepticus].
  2. Valproate-related hyperammonemic encephalopathy with generalized suppression EEG: a case report.
  3. What about children treated with valproate?
  4. Valproate is contraindicated in pregnancy.
  5. [Valproate can induce reversible encephalopathy].
  6. Non-hyperammonaemia valproate-induced encephalopathy: A case report.
  7. [A severe, reversible encephalopathy after prolonged use of valproic acid].
  8. Cerebral and cerebellar pseudoatrophy associated with valproic acid. Report of three pediatric cases.
  9. Effects of l-carnitine supplementation in patients with childhood-onset epilepsy prescribed valproate.
  10. HYPERAMMONAEMIA AND COGNITIVE IMPAIRMENT IN EPILEPSY PATIENTS TREATED WITH VALPROIC ACID - PRELIMINARY STUDY.